Recalled ranitidine drugs had excessive amounts of NDMA carcinogen

KUALA LUMPUR: Ten recalled drugs containing the active ingredient ranitidine that treats stomach ulcers have been confirmed to contain the impurity N-Nitrosodimethylamine (NDMA) above the permitted level, said the Health Ministry.

Health director-general Datuk Dr Noor Hisham Abdullah said that the recall was based on evaluations and laboratory tests carried out by the ministry and companies holding the drug registrations, as well as information from international regulatory bodies.